HR2PM2

General Information


DCTPep ID  DCTPep02753

Peptide Name   HR2PM2

Sequence  SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL

Sequence Length  36

UniProt ID  K9N5Q8 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Lipopeptides



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
Huh-7 Adult hepatocellular carcinoma; Adult hepatocellular carcinoma CC50>100 µM CCK-8 assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep02753

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C193H321N43O64S1

Absent amino acids  ACFGHPRW

Theoretical pI  4.48

Acidic residues  9

Basic residues  5

Polar residues  8

Molecular weight (Average)  4299.98

Molecular weight (Monoisotopic)  4297.29

Common amino acids  L

Net charge  -4

Instability index (II)  18.76

Aliphatic index  124.44

Grand average of hydropathicity (GRAVY)  -0.406

Half Life 
  1.9 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 2980
  Abs 0.1% (=1 g/l) 0.693

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30192544

Title  De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery

Doi 10.1021/acs.jmedchem.8b00890

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_15196

DCTPep is developed by Dr.Zheng's team.